FOXA2 and breast cancer: Another study found that TLE3, a transcription corepressor recruited by FOXA2 to the ZEB2 promoter, inhibits the expression of the EMT-related transcription factor ZEB2, thereby suppressing the EMT of breast cancer cells [32].